JTT 302

Drug Profile

JTT 302

Alternative Names: JTT-302

Latest Information Update: 08 Aug 2013

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Japan Tobacco
  • Class Antihyperlipidaemics
  • Mechanism of Action Cholesterol ester transfer protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Hyperlipidaemia

Most Recent Events

  • 30 Jul 2013 Discontinued - Phase-II for Hyperlipidaemia (PO)
  • 27 Apr 2007 Phase-II clinical trials in Hyperlipidaemia (PO)
  • 18 Apr 2005 Phase-I clinical trials in Hyperlipidaemia (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top